Alpine Immune Sciences Inc (ALPN)
64.70
+0.04
(+0.06%)
USD |
NASDAQ |
May 08, 15:45
Alpine Immune Sciences 1 Year Total Returns (Daily): 775.0% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 07, 2024 | 775.0% |
| May 06, 2024 | 774.2% |
| May 03, 2024 | 824.2% |
| May 02, 2024 | 812.4% |
| May 01, 2024 | 762.5% |
| April 30, 2024 | 762.3% |
| April 29, 2024 | 763.8% |
| April 26, 2024 | 795.4% |
| April 25, 2024 | 811.4% |
| April 24, 2024 | 801.8% |
| April 23, 2024 | 801.5% |
| April 22, 2024 | 802.0% |
| April 19, 2024 | 765.3% |
| April 18, 2024 | 762.5% |
| April 17, 2024 | 765.2% |
| April 16, 2024 | 782.4% |
| April 15, 2024 | 781.3% |
| April 12, 2024 | 787.9% |
| April 11, 2024 | 755.2% |
| April 10, 2024 | 507.0% |
| April 09, 2024 | 414.4% |
| April 08, 2024 | 409.0% |
| April 05, 2024 | 368.0% |
| April 04, 2024 | 369.2% |
| April 03, 2024 | 371.1% |
| Date | Value |
|---|---|
| April 02, 2024 | 407.9% |
| April 01, 2024 | 421.0% |
| March 28, 2024 | 449.0% |
| March 27, 2024 | 452.1% |
| March 26, 2024 | 402.7% |
| March 25, 2024 | 404.0% |
| March 22, 2024 | 397.3% |
| March 21, 2024 | 419.4% |
| March 20, 2024 | 393.0% |
| March 19, 2024 | 365.1% |
| March 18, 2024 | 312.9% |
| March 15, 2024 | 352.5% |
| March 14, 2024 | 356.0% |
| March 13, 2024 | 393.4% |
| March 12, 2024 | 404.1% |
| March 11, 2024 | 389.3% |
| March 08, 2024 | 341.4% |
| March 07, 2024 | 352.3% |
| March 06, 2024 | 384.3% |
| March 05, 2024 | 369.0% |
| March 04, 2024 | 358.8% |
| March 01, 2024 | 350.6% |
| February 29, 2024 | 341.9% |
| February 28, 2024 | 338.1% |
| February 27, 2024 | 357.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.73%
Minimum
Mar 17 2020
824.2%
Maximum
May 03 2024
66.23%
Average
0.11%
Median
Jun 08 2022
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals Inc | 17.87% |
| Eliem Therapeutics Inc | 202.4% |
| Regeneron Pharmaceuticals Inc | 27.28% |
| Vera Therapeutics Inc | 505.1% |
| Eyenovia Inc | -82.30% |